A Swiss microbiota company with two technology platforms: ApyraVax for innovative mucosal vaccines against enteric infections; ApyraMed for live modified biotherapeutics with 2 lead products with indication in cancer immunotherapy of solid tumors and dysbiosis by antibiotics and unhealthy diet.


Via Belsoggiorno 1, 6500 Bellinzona, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation


  • Number of employees in Switzerland


Key business